Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07216261 · ClinicalTrials.gov registry record · NA

Implementing Cognitive Behavioral Therapy for Insomnia (SWELL): Function QUERI 3.0

A NA study, sponsored by VA Office of Research and Development.

Recruiting
Registry status
NA
Development phase
20
Enrollment target

NCT07216261: Recruiting NA study, sponsored by VA Office of Research and Development.

NCT07216261 is a NA study that is actively recruiting participants, run by VA Office of Research and Development. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT07216261, a NA study, is actively recruiting participants, sponsored by VA Office of Research and Development.

RECRUITING
Registry status
NA
Development phase
20 participants
Enrollment target

Study Summary

Implementing Cognitive Behavioral Therapy for Insomnia with Older Veterans (SWELL): Function QUERI 3.0 aims to compare implementation approaches while also gathering information on clinical effectiveness of the EBP in its new context. The overall goal is to implement, evaluate, and sustain SWELL in 20 VA facilities using a type III effectiveness-implementation hybrid study framework and parallel cluster randomized trial (CRT) design.

Primary Outcome

Reach will be defined as the number of older Veterans who initiate SWELL at a site. Initiation is defined as completing the first SWELL treatment session.

Interventions

  • OTHER Implementation Strategy: Foundational Arm
  • OTHER Implementation Strategy: REACH arm

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2026-04-30
Est. Completion 2030-09-30
Phase NA
VA Office of Research and Development

1,668 total trials

What NCT07216261 shows while recruiting

NCT07216261 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 2 interventions - of which Implementation Strategy: Foundational Arm is the first listed.

NCT07216261 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT07216261 about?

NCT07216261 is a clinical study titled "Implementing Cognitive Behavioral Therapy for Insomnia (SWELL): Function QUERI 3.0". Implementing Cognitive Behavioral Therapy for Insomnia with Older Veterans (SWELL): Function QUERI 3.0 aims to compare implementation approaches while also gathering information on clinical effectiveness of the EBP in its new context. The overall goal is to implement, evaluate, and sustain SWELL in ...

What is the current status of trial NCT07216261?

This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2026-04-30. Estimated completion is 2030-09-30.

What interventions are being tested in trial NCT07216261?

The interventions under investigation include: Implementation Strategy: Foundational Arm (OTHER), Implementation Strategy: REACH arm (OTHER).

Who is sponsoring clinical trial NCT07216261?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT07216261's enrollment target sits among peer trials

20 1768th of 2000 higher than 140 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07216261, the US trial registry maintained by the National Library of Medicine. NCT07216261 (small enrollment · none site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.